Page results
-
Prime Minister, Sir Keir Starmer, was joined by Health and Social Care Secretary, Wes Streeting, for a tour of the University College Hospital Grafton Way Building where they met staff and patients.
-
There’s a lot of information available out there. Here you can find information about type 1 and type 2 diabetes.
-
Patient story - Zehavah Handler - When sleep becomes a nightmare. Zehavah Handler struggled to sleep for 25 years before completing a five-week course at UCLH’s insomnia clinic. Here, she tells us how it changed her life.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to the eye (orbit). There are different conditions that may require radiotherapy to the eye such as retinoblastoma, orbital rhabdomyosarcomas, soft tissue sarcomas, lymphomas, or some other condition.
-
Paediatric Audio-vestibular Medicine provides investigation, diagnosis and management of the medical aspect of disorders of hearing, balance and tinnitus in children. The service consists of a multi-professional team and is located at The Royal National ENT & Eastman Dental Hospitals, 47-49 Huntley Street London WC1E 6DG.
-
The service includes diagnosis, quantifying the degree of hearing loss, and rehabilitation of hearing impairment to limit participation restriction.
-
Paediatric audiology is based at the Royal National ENT & Eastman Dental Hospital. The service provides Audiological assessments for children ranging from new-borns to 18 year olds.
-
We are a specialist psychological team situated within the paediatric Audio-Vestibular Medical Services. We work psychologically with children, young people and their families who experience AVM conditions and also particular types of referrals, specifically tinnitus, hyperacusis and misophonia, from outside the hospital.
-
Information about energy conservation for UCLH patients with mitochondrial disease.
-
Irreversible Electroporation for Prostate Cancer (IRE or Nanoknife™) patient information page.
File results
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain
-
FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services
-
FOI/2022/0226 - Treatments for Haemophilia A
-
FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust
-
FOI/2022/0230 - Fabry, Gaucher and Pompe diseases drug treatments
-
FOI/2022/0232 - Number of patients who have died while waiting for elective care
-
FOI/2022/0233 - Diagnosis/ treatment of epilepsy, dravet syndrome, lennox gastaut syndrome and tuberous sclerosis complex